Significant Ownership of CVI Investments, Inc.

Signature - Title
/s/ Sarah Travis - Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc.
Location
Grand Cayman, Cayman Islands
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by CVI Investments, Inc..

Notify me when CVI Investments, Inc. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of CVI Investments, Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SLDP Solid Power, Inc. Common Stock, $0.0001 par value per share 9.9% $89,721,410 21,110,920 CVI Investments, Inc. 28 Jan 2026
LAES SEALSQ Corp Ordinary Shares, $0.01 par value per share 9.9% $84,860,982 +$12,407,680 19,689,323 +17% CVI Investments, Inc. 31 Dec 2025
NYXH Nyxoah SA Ordinary Shares, no par value 9.9% $21,261,401 4,683,128 CVI Investments, Inc. 18 Dec 2025
BMEA Biomea Fusion, Inc. Common Stock, $0.0001 par value per share 9.9% $11,927,793 +$2,131,163 7,847,232 +22% CVI Investments, Inc. 31 Dec 2025
CTXR Citius Pharmaceuticals, Inc. Common Stock, $0.001 par value per share 9.9% $2,059,464 +$635,578 2,394,725 +45% CVI Investments, Inc. 31 Dec 2025
BNGO Bionano Genomics, Inc. Common Stock, $0.0001 par value per share 9.9% $1,795,763 +$171,307 1,129,411 +11% CVI Investments, Inc. 31 Dec 2025
PHIO Phio Pharmaceuticals Corp. Common Stock, $0.0001 par value per share 9.9% $1,409,768 +$544,422 1,194,719 +63% CVI Investments, Inc. 31 Dec 2025
APVO Aptevo Therapeutics Inc. Common Stock, $0.001 par value per share 9.9% $1,073,526 357,842 CVI Investments, Inc. 30 Jun 2025
DCOY Decoy Therapeutics Inc. (f/k/a Salarius Pharmaceuticals, Inc.) Common Stock, $0.0001 par value per share 9.9% $885,706 +$432,582 708,565 +95% CVI Investments, Inc. 31 Dec 2025
SXTP 60 Degrees Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 9.9% $670,061 +$187,456 455,545 +39% CVI Investments, Inc. 30 Sep 2025
PCSA Processa Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share 9% $959,500 +$101,502 5,000,000 +12% CVI Investments, Inc. 30 Sep 2025
APVO Aptevo Therapeutics Inc. Common Stock, $0.001 par value per share 8.2% $744,624 83,854 CVI Investments, Inc. 31 Dec 2025
NA Nano Labs Ltd Class A Ordinary Shares, $0.002 par value per share 8.1% $9,779,578 -$1,615,502 1,811,033 -14% CVI Investments, Inc. 30 Sep 2025
FGMCU FG Merger II Corp. Common Stock, par value $0.0001 per share 7.7% $7,742,000 790,000 CVI Investments, Inc. 29 Jan 2025
BNGO Bionano Genomics, Inc. Common Stock, par value $0.0001 per share 7.7% $1,284,000 10,700,000 CVI Investments, Inc. 03 Jan 2025
DPRO Draganfly Inc. Common Shares, no par value 7.1% $19,154,686 -$1,230,829 1,950,579 -6% CVI Investments, Inc. 31 Dec 2025
PSTV Plus Therapeutics, Inc. Common Stock, $0.001 par value per share 6.9% $4,935,001 12,368,423 CVI Investments, Inc. 14 Jan 2026
ICON Icon Energy Corp. Common Stock, par value $0.001 per share 6.9% $36,700 734,000 CVI Investments, Inc. 23 Jan 2025
APVO Aptevo Therapeutics Inc. Common Stock, $0.001 par value per share 6.2% $138,000 200,000 CVI Investments, Inc. 03 Apr 2025
ATOM Atomera Incorporated Common Stock, $0.001 par value per share 5.8% $6,405,000 2,100,000 CVI Investments, Inc. 23 Feb 2026
HSDT Helius Medical Technologies, Inc. Class A Common Stock, par value $0.001 per share 5.8% $787,000 183,450 CVI Investments, Inc. 04 Jun 2025
BCTX BriaCell Therapeutics Corp. Common Shares, no par value 5.7% $2,960,000 +$1,906,577 1,000,000 +181% CVI Investments, Inc. 15 Jul 2025
RSLS ReShape Lifesciences Inc. Common Stock, par value $0.001 per share 5.7% $76,000 -$54,958 200,000 -42% CVI Investments, Inc. 31 Mar 2025
Newbridge Acquisition Limited Class A Ordinary Shares, no par value 5.6% 300,000 CVI Investments, Inc. 29 Jan 2026
INVZ Innoviz Technologies Ltd. Ordinary Shares, no par value 5.5% $8,517,985 -$6,576,480 11,510,791 -44% CVI Investments, Inc. 31 Mar 2025
MBOT Microbot Medical Inc. Common Stock, par value $0.01 per share 4.9% $4,780,994 +$1,487,280 1,824,807 +45% CVI Investments, Inc. 31 Mar 2025
INMB INmune Bio Inc. Common Stock, $0.001 par value per share 4.9% $3,225,404 -$239,596 1,396,279 -6.9% CVI Investments, Inc. 30 Jun 2025
ANVS Annovis Bio, Inc. Common Stock, par value $0.0001 per share 4.9% $1,470,000 1,000,000 0% CVI Investments, Inc. 31 Mar 2025
RVPH Reviva Pharmaceuticals Holdings, Inc. Common Stock, $0.0001 par value per share 4.9% $1,392,925 -$167,075 3,571,603 -11% CVI Investments, Inc. 30 Jun 2025
BCTX BriaCell Therapeutics Corp. Common Shares, no par value 4.9% $1,088,384 98,944 CVI Investments, Inc. 30 Sep 2025
SLXN Silexion Therapeutics Corp Ordinary Shares, par value $0.0009 per share 4.9% $424,574 +$109,304 456,531 +35% CVI Investments, Inc. 31 Mar 2025
GXAI Gaxos.ai Inc. Common Stock, par value $0.0001 per share 4.9% $410,896 -$162,293 363,625 -28% CVI Investments, Inc. 31 Dec 2024
AMIX Autonomix Medical, Inc. Common Stock, $0.001 par value per share 4.9% $293,700 116,087 CVI Investments, Inc. 31 Dec 2024
DFSC DEFSEC Technologies Inc. Common Shares, no par value 4.9% $250,692 -$95,572 70,419 -28% CVI Investments, Inc. 30 Sep 2025
TOVX Theriva Biologics, Inc. Common Stock, $0.001 par value per share 4.9% $206,052 146,136 CVI Investments, Inc. 31 Dec 2024
JAGX Jaguar Health, Inc. Common Stock, $0.0001 par value per share 4.6% $346,470 +$36,300 164,204 +12% CVI Investments, Inc. 30 Sep 2025
ATOS Atossa Therapeutics, Inc. Common Stock, $0.18 par value per share 4.3% $4,530,000 5,662,500 CVI Investments, Inc. 31 Dec 2024
KTTA Pasithea Therapeutics Corp. Common Stock, $0.0001 par value per share 3.8% $791,995 +$64,987 899,994 +8.9% CVI Investments, Inc. 31 Dec 2025
PSQH PSQ Holdings, Inc. Class A Common Stock, $0.0001 par value per share 3.3% $2,699,361 1,285,410 CVI Investments, Inc. 31 Dec 2024
GLMD Galmed Pharmaceuticals Ltd. Ordinary Shares, NIS 1.80 par value per share 3.1% $346,666 173,333 0% CVI Investments, Inc. 30 Sep 2025
AEI Alset Inc. Common Stock, $0.001 par value per share 0.4% $38,000 -$674,500 40,000 -95% CVI Investments, Inc. 31 Mar 2025
SIDU Sidus Space, Inc. Class A Common Stock, $0.0001 par value per share 0.3% $668,448 -$11,771,552 214,935 -95% CVI Investments, Inc. 31 Dec 2025
DFLI Dragonfly Energy Holdings Corp. Common Stock, $0.0001 par value per share 0.2% $66,089 -$2,194,151 111,111 -97% CVI Investments, Inc. 30 Sep 2025
BTM Bitcoin Depot Inc. Class A Common Stock, $0.0001 par value per share 0% $0 -$2,764,287 0 -100% CVI Investments, Inc. 31 Dec 2025
ICON Icon Energy Corp. Common Shares, par value $0.001 per share 0% $0 0 CVI Investments, Inc. 31 Mar 2025
RVYL RYVYL Inc. Common Stock, $0.001 par value per share 0% $0 -$611,733 0 -100% CVI Investments, Inc. 30 Jun 2025
SRFM Surf Air Mobility Inc. Common Stock, $0.0001 par value per share 0% $0 -$23,498,000 0 -100% CVI Investments, Inc. 30 Jun 2025
CADL Candel Therapeutics, Inc. Common Stock, $0.01 par value per share 0% $0 0 CVI Investments, Inc. 31 Dec 2024
SONM Sonim Technologies, Inc. Common Stock, $0.001 par value per share 0% $0 -$650,000 0 -100% CVI Investments, Inc. 30 Sep 2025
BTCT BTC Digital Ltd. Ordinary Shares, $0.06 par value per share 0% $0 -$1,375,000 0 -100% CVI Investments, Inc. 30 Sep 2025
HSDT Helius Medical Technologies, Inc. Class A Common Stock, $0.001 par value per share 0% $0 0 CVI Investments, Inc. 30 Jun 2025
RSLS ReShape Lifesciences Inc. Common Stock, $0.001 par value per share 0% $0 0 CVI Investments, Inc. 30 Jun 2025
SSKN STRATA Skin Sciences, Inc. Common Stock, $0.001 par value per share 0% $0 -$753,539 0 -100% CVI Investments, Inc. 30 Sep 2025
RGTI Rigetti Computing, Inc. Common Stock, $0.0001 par value per share 0% $0 0 CVI Investments, Inc. 31 Dec 2024
GAME GameSquare Holdings, Inc. Common Stock, $0.0001 par value per share 0% $0 -$3,394,000 0 -100% CVI Investments, Inc. 30 Sep 2025
FLUX Flux Power Holdings, Inc. Common Stock, $0.001 par value per share 0% $0 -$1,524,000 0 -100% CVI Investments, Inc. 31 Dec 2025
LITM Snow Lake Resources Ltd. Common Shares, no par value 0% $0 -$2,200,000 0 -100% CVI Investments, Inc. 31 Dec 2024

Schedules 13D/G Reported by CVI Investments, Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.